166 related articles for article (PubMed ID: 22796099)
1. The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment.
Wang Y; Liu X; Yu Y; Han Y; Wei J; Collier D; Li T; Ma X
Psychiatry Res; 2012 Dec; 200(2-3):1047-50. PubMed ID: 22796099
[TBL] [Abstract][Full Text] [Related]
2. TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
Yin L; Zhang YY; Zhang X; Yu T; He G; Sun XL
Pharmacopsychiatry; 2015 May; 48(3):95-103. PubMed ID: 25642918
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
[TBL] [Abstract][Full Text] [Related]
4. No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors.
Serretti A; Zanardi R; Cusin C; Rossini D; Lilli R; Lorenzi C; Lattuada E; Smeraldi E
Psychiatry Res; 2001 Nov; 104(3):195-203. PubMed ID: 11728608
[TBL] [Abstract][Full Text] [Related]
5. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
6. [Association of TPH2 gene polymorphism with response to antidepressant treatment among ethnic Han Chinese population].
Yu J; Dong Z; Yu T; Li X; Sun X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):567-571. PubMed ID: 30098258
[TBL] [Abstract][Full Text] [Related]
7. Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder.
Firouzabadi D; Firouzabadi N; Kalani K; Zomorrodian K; Tehrani ES
Eur J Clin Pharmacol; 2019 Feb; 75(2):189-194. PubMed ID: 30324302
[TBL] [Abstract][Full Text] [Related]
8. Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population.
He M; Yan H; Duan ZX; Qu W; Gong HY; Fan ZL; Kang JY; Li BC; Wang JM
Int J Clin Exp Pathol; 2013; 6(6):1142-9. PubMed ID: 23696934
[TBL] [Abstract][Full Text] [Related]
9. Catecholamine pathway polymorphisms and antidepressant response.
Yin L; Zhang X; Huang Y; Sun X
Asia Pac Psychiatry; 2016 Jun; 8(2):109-17. PubMed ID: 25854875
[TBL] [Abstract][Full Text] [Related]
10. GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.
Kishi T; Ichinose H; Yoshimura R; Fukuo Y; Kitajima T; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Musso GM; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
J Affect Disord; 2012 Dec; 142(1-3):315-22. PubMed ID: 22770721
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder.
Illi A; Setälä-Soikkeli E; Kampman O; Viikki M; Nuolivirta T; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
Psychiatry Res; 2010 Mar; 176(1):85-7. PubMed ID: 20071037
[TBL] [Abstract][Full Text] [Related]
12. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
13. Association Between
Xu Y; Ma H; Zhao T; Wen D; Wen Y; Qiao D; Liu Z
Genet Test Mol Biomarkers; 2019 Dec; 23(12):843-849. PubMed ID: 31692380
[No Abstract] [Full Text] [Related]
14. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
[TBL] [Abstract][Full Text] [Related]
15. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
[TBL] [Abstract][Full Text] [Related]
17. Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts.
Ward J; Graham N; Strawbridge RJ; Ferguson A; Jenkins G; Chen W; Hodgson K; Frye M; Weinshilboum R; Uher R; Lewis CM; Biernacka J; Smith DJ
PLoS One; 2018; 13(9):e0203896. PubMed ID: 30240446
[TBL] [Abstract][Full Text] [Related]
18. Genetic prediction of antidepressant drug response and nonresponse in Korean patients.
Lim SW; Won HH; Kim H; Myung W; Kim S; Kim KK; Carroll BJ; Kim JW; Kim DK
PLoS One; 2014; 9(9):e107098. PubMed ID: 25226239
[TBL] [Abstract][Full Text] [Related]
19. Association between the TPH1 A218C polymorphism and antidepressant response: evidence from an updated ethnicity, antidepressant-specific, and ethnicity-antidepressant interaction meta-analysis.
Zhao X; Huang Y; Li D; Han C; Kan Q
Psychiatr Genet; 2015 Feb; 25(1):1-8. PubMed ID: 25419635
[TBL] [Abstract][Full Text] [Related]
20. Association analysis of SIGMAR1 with major depressive disorder and SSRI response.
Kishi T; Yoshimura R; Okochi T; Fukuo Y; Kitajima T; Okumura T; Tsunoka T; Kawashima K; Yamanouchi Y; Kinoshita Y; Umene-Nakano W; Naitoh H; Nakamura J; Ozaki N; Iwata N
Neuropharmacology; 2010 Jun; 58(7):1168-73. PubMed ID: 20178807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
